• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Otolaryngologists Can Play Vital Role in Helping Patients Manage Depression

by Mary Beth Nierengarten • April 12, 2016

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Both Dr. Andersen and Dr. Kendall believe that a major challenge for physicians is knowing where to refer patients when screening indicates they may need follow-up for depression. “The ASCO guidelines specify that referral for further evaluation of appropriate treatment is needed to address specific symptom levels,” said Dr. Andersen. “The challenge is for providers to identify specific referral resources in their facility and their community.”

You Might Also Like

  • Diagnosing and Treating Depression in Head and Neck Cancer Patients
  • Should Patients with Obstructive Sleep Apnea Be Screened for Depression?
  • Should Patients with OSA Be Screened for Depression?
  • Depression, Anxiety Rarely Assessed in Patients with Otolaryngologic Disorders
Explore This Issue
April 2016

Both recommend that physicians look carefully at the resources within their institutions, as well as in the community, and establish relationships, just as they do for any other referral pathway. “The longer-term issue is the need for more resources and more trained professionals, such as psychologists and social workers, within cancer programs,” said Dr. Kendall. “We’ve all been mandated to do distress screening, but there has been no money allocated to do that.”

To help otolaryngologists implement screening as well as develop referral pathways for assessment and treatment, Dr. Kendall also suggested seeking guidance from organizations that understand these issues. Recently, a joint task force comprising the American Psychosocial Oncology Society (APOS), the Association of Oncology Social Work (AOSW), and the Oncology Nursing Society (ONS) developed consensus-based recommendations based on six components of the CoC Standard 3.2 (Cancer. 2014;120:2946-2954), including:

  1. psychosocial representation on the cancer committee with a committee meeting that includes plans for screening;
  2. timing of screening;
  3. method and mode of screening;
  4. tools for screening;
  5. assessment and referral; and
  6. documentation.

Screening is just the first step to address potential depression in patients with cancer, but because referral for further assessment and treatment is needed for patients once they have been screened and identified with depression, clinics should put in place referral pathways prior to screening to ensure optimal treatment.

Prophylactic Treatment of Depression

Another approach that clinicians may think about is the use of prophylactic antidepressants to reduce the risk of cancer patients developing depression. This was suggested in a study by Lydiatt and colleagues, who found that prophylactically treating nondepressed patients undergoing treatment for head and neck cancer reduced the risk of depression by more than 50%, and that patients who were treated and were not depressed reported significantly better quality of life for three months after stopping the antidepressant (JAMA Otolaryngol Head Neck Surg. 2013;139:678-686).

William Lydiatt, MD, professor and vice chair of the department of otolaryngology and director of head and neck surgery at the University of Nebraska Medical Center in Omaha, said that both initial screening for depression and prophylactic antidepressants in nondepressed patients with head and neck cancer should be employed. “Initial screening should be done to determine if the patient is already depressed,” he said, noting that up to 15% of people are depressed at baseline and will have a worse prognosis.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider Tagged With: depression, head and neck cancer, mortality, otolaryngologyIssue: April 2016

You Might Also Like:

  • Diagnosing and Treating Depression in Head and Neck Cancer Patients
  • Should Patients with Obstructive Sleep Apnea Be Screened for Depression?
  • Should Patients with OSA Be Screened for Depression?
  • Depression, Anxiety Rarely Assessed in Patients with Otolaryngologic Disorders

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939